<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The body has an elaborate system that maintains blood circulation and rapidly stops <z:mp ids='MP_0001914'>bleeding</z:mp> when vessels are damaged </plain></SENT>
<SENT sid="1" pm="."><plain>Abnormalities that disrupt this balance may lead to <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>While beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I is generally accepted as the major antigen for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, our accumulated studies show that some <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> bind homologous enzymatic domains of several serine proteases involved in hemostasis and fibrinolysis </plain></SENT>
<SENT sid="3" pm="."><plain>Functionally, some of the protease-reactive <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> hinder <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> regulation and resolution of clots, thus tip the balance toward <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Intriguingly, several serine protease-reactive <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> also react with beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I, and interactions between <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and antigens are cross-inhibited, indicating that these <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> recognize conformational <z:chebi fb="0" ids="53000">epitope</z:chebi>(s) on beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I and target serine proteases </plain></SENT>
<SENT sid="5" pm="."><plain>Viewed as a whole, these results extend previous reports that <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> bind to various hemostasis factors, and provide a new perspective about some <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in terms of their binding specificities and related functional properties in promoting <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>